Using transgenic mice expressing the herpes simplex virus thymidine kinase gene under the control of the Cd11b promoter, Galarneau et al. have shown that targeted reduction of CD11b+ microglia and macrophages concomitantly results in attenuated glioma growth in vivo [44, 90]. The gene discussed is ITGAM; the disease is glioma.